Pfizer has met its commitment to have 120 million doses of its Covid-19 vaccine released and ready for shipment to the US by the end of March, the company said on Wednesday.
The company confirms it remains on track for its May and July goals as well.
At the end of February, Pfizer’s Chief Business Officer John Young’s written testimony to the United States House Committee on Energy and Commerce Oversight and Investigations said:
"We are on track to make 120 million doses available for shipment by the end of March and an additional 80 million doses by the end of May. And, we anticipate all 300 million contracted doses will be made available for shipment by the end of July, enabling the vaccination of up to 150 million Americans."
So far, Pfizer says it has shipped more than 100 million doses to the US.
As of Wednesday, the US Centers for Disease Control and Prevention data showed that more than 75 million doses of Pfizer’s Covid-19 vaccine have been administered in the US and more than 95 million doses have been delivered.